Covered recipient · General Payments record
WAYNE C LUE
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$3,438.96
- Reported across 149 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $181.32 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $47.02 | 3 |
| Madrigal Pharmaceuticals | $27.07 | 1 |
| Phathom Pharmaceuticals, Inc. | $20.53 | 1 |
| EVOKE PHARMA, INC. | $20.37 | 1 |
| Lilly USA, LLC | $18.45 | 1 |
| VIVUS LLC | $18.20 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.60 | 1 |
| Braintree Laboratories, Inc. | $13.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.91 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104909990 | CMS |
| ABBVIE INC. | $18.13 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104909992 | CMS |
| ABBVIE INC. | $13.98 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104909994 | CMS |
| Braintree Laboratories, Inc. | $13.08 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125516015 | CMS |
| EVOKE PHARMA, INC. | $20.37 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127779327 | CMS |
| Lilly USA, LLC | $18.45 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135441365 | CMS |
| Madrigal Pharmaceuticals | $27.07 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144174559 | CMS |
| Phathom Pharmaceuticals, Inc. | $20.53 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151090865 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.60 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137625020 | CMS |
| VIVUS LLC | $18.20 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129416804 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.